Prostate Cancer Clinical Trials in Los Angeles

Showing 161-173 of 173 trials

Extension to Study of Effects of Pomegranate Extract on Rising PSA Levels After Primary Therapy for Prostate Cancer

NCT00732043

High concentrations of anti-oxidants in pomegranate seeds present a potential strategy to delay clinical prostate cancer progression and prolong the interval from primary treatment failure to hormonal ablation. This is a 48 month extension to the double-blind GUP-0205-1 study, to compare the effects of daily consumption of pomegranate liquid extract versus placebo on the absolute prostate-specific antigen (PSA) doubling time at the end of 12, 24, 36 and 48 months in male subjects who rolled-over from the GUP-0205-1 study.

Prostate Cancer

Roll International Corporation200 participantsStarted Dec 2007

Los Angeles, California, United States

UNKNOWNPHASE2/PHASE3< 1 mile

ASCENT: Androgen Independent Prostate Cancer Study of Calcitriol Enhancing Taxotere

NCT00043576

The purposes of this study are to determine if DN-101 plus Taxotere lowers PSA levels, delays or limits disease progression and is safe with minimal side effects.

Prostate Cancer

Novacea250 participantsStarted Aug 2002

Montgomery, Alabama, United States • Scottsdale, Arizona, United States • Tucson, Arizona, United States +59 more locations

Extension to Study of Effects of Pomegranate Extract on Rising PSA Levels After Primary Therapy for Prostate Cancer

ASCENT: Androgen Independent Prostate Cancer Study of Calcitriol Enhancing Taxotere

Prostate Cancer Trials in Other Cities

Study of AS1404 With Docetaxel in Patients With Hormone Refractory Metastatic Prostate Cancer

Docetaxel in Combination With GVAX ® Immunotherapy Versus Docetaxel and Prednisone in Prostate Cancer Patients

The Efficacy and Safety of Degarelix One Month Dosing Regimens in Prostate Cancer

Bicalutamide (Casodex™) Versus Placebo in Patients With Early Prostate Cancer

YM598 Added to Mitoxantrone/Prednisone to Control Pain in Metastatic Prostate Cancer Patients No Longer Responding to Hormone Therapy

A Comparative Study of Degarelix Three-month Depot in Three Different Dosing Regimens in Patients With Prostate Cancer

Molecular Urine Tests for Prostate Cancer

A Phase I Pilot Study Comparing 123I MIP 1072 Versus 111In Capromab Pendetide in Subjects With Metastatic Prostate Cancer

Study of Abarelix in Androgen-Independent Prostate Cancer Progressing After Agonist Therapy

A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors

A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone Acetate in Male Participants With Prostate Cancer

Other Conditions in Los Angeles